Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

First Franchise Urgent Care Clinic to Open

September 27, 2010 12:31 am | by San Diego Business Journal | News | Comments

A longtime local health care executive is hoping to attract some of the county’s urgent care business when he opens the first franchise clinic of a national chain tailored to these types of patients.

TOPICS:

Hospital Bond Watchdog Panel Reorganizes

September 26, 2010 11:31 pm | by San Diego Business Journal | News | Comments

Keeping an eye on one government agency’s coffers is part of the business at hand for a citizens’ oversight committee created four years ago to monitor officials and their allocation of bond funds at Grossmont Healthcare District.

TOPICS:

UM School of Medicine Center for Celiac Research finds rate of celiac disease is growing

September 26, 2010 10:31 pm | by EurekAlert | News | Comments

(University of Maryland Medical Center) The number of celiac disease cases in the US has doubled every 15 years since 1974, increasing particularly among older people, according to a new study from the University of Maryland School of Medicine's Center for Celiac Research. As people in...

TOPICS:
Advertisement

Genetic "Light Switches" Control Muscle Movement

September 26, 2010 8:32 pm | by Massachusetts Institute of Technology | News | Comments

The technique will improve research on neuromuscular disorders and could one day help paralyzed patients.

Hospira Receives TGA Approval for Nivestim™, Australia's First Biosimilar Filgrastim

September 26, 2010 4:35 pm | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, Sept. 26 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced that it has received Australian Therapeutic Goods Administration (TGA) approval for its biosimilar filgrastim product, Nivestim™. Nivestim has been...

TOPICS:

Genetic ancestry: A new look at racial disparities in head and neck cancer

September 26, 2010 9:36 am | by EurekAlert | News | Comments

(Henry Ford Health System) Head and neck cancer outcomes associated with race may be more closely linked to social and behavioral factors than biological differences, especially for African-Americans, according to a new Henry Ford Hospital study. Researchers found that while those...

TOPICS:

Stress can control our genes

September 26, 2010 5:34 am | by EurekAlert | News | Comments

(University of Copenhagen) Researchers from Dr. Klaus Hansen's laboratory at BRIC, University of Copenhagen, have just shown that stress-factors can control our genes: Exposing human cells to a stress-activating compound turned on genes that are normally silenced. Protective...

TOPICS:

2010 AAO-HNSF new research daily highlights: Sunday, Sept. 26, 2010

September 26, 2010 5:34 am | by EurekAlert | News | Comments

(American Academy of Otolaryngology -- Head and Neck Surgery) Featuring more than 305 scientific research sessions, 594 posters and several hundred instruction course hours for attendees, the annual meeting is a unique opportunity for journalists from around the world to cover...

TOPICS:
Advertisement

Invensense IPO will change the competition in the motion sensing business

September 25, 2010 11:33 am | by I-Micronews | News | Comments

Business is there: moving from $300M in 2009 to $1.2B in 2015 only for smart phones

Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare Diseases

September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

DULUTH, Minn., Sept. 25 /- CSL Plasma , one of the world's largest collectors of human plasma, is honoring donors from the Duluth area today as part of a statewide observance of "Plasma Protein Therapies Month." According to Randy Furby, Senior Vice President and General Manager of CSL...

TOPICS:

HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients

September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Sept. 25 /- Boston Scientific Corporation (NYSE: BSX ) today announced three-year follow-up data from the HORIZONS-AMI trial.  The trial, sponsored by the Cardiovascular Research Foundation (CRF) with grant support from Boston Scientific and The Medicines Company...

TOPICS:

Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT ...

September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 25 /- OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell (EPC) capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture...

TOPICS:

HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients

September 25, 2010 9:31 am | by Boston Scientific | News | Comments

NATICK, Mass., Sept. 25 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced three-year follow-up data from the HORIZONS-AMI trial.  The trial, sponsored by the Cardiovascular Research Foundation (CRF) wi

TOPICS:

Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardi...

September 25, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, Sept. 25 /- Today Astellas Pharma US, Inc. ("Astellas") announced results of a Phase IV study showing Lexiscan® (regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or...

TOPICS:

Epogen and Procrit (epoetin alfa): Recall - Particulate Matter in Vials

September 24, 2010 4:33 pm | by U.S. Food & Drug Administration | News | Comments

Recall due to risks of embolic, thrombotic and other vascular serious adverse events.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading